Tagged Articles

diabetes 222 articles

FDA warns consumers against unapproved diabetes treatments

The Food and Drug Administration (FDA) is warning consumers not to fall for products that claim to prevent, treat and even cure diabetes because they may contain harmful ingredients or be otherwise unsafe. These illegal products can pose an additional risk if they cause consumers to delay or discontinue effective treatments for diabetes. Without proper diabetes management, diabetics are at greater risk for developing serious health complications. The FDA has launched a new initiative to stop the sale of these bogus diabetes products and has issued warning letters to 15 companies to let them know selling these products is in violation of ... Read More

Nova diabetes test strips recalled

Several lots of Nova Max Glucose Test Strips used to test blood sugar levels  are being recalled because they may report a false, abnormally high blood glucose result. This defect could, under certain conditions, result in an insulin dosing error that could lead to serious health risks requiring immediate medical attention. The recall, initiated by Nova Diabetes Care, affects 21 lots of Nova Max Glucose Test Strips and Nova Max Plus glucose meter kits that include the test strips. The affected products were distributed both within and outside the continental USA. Nova Diabetes Care has notified all registered users, health ... Read More

New diabetes drug controls blood sugar better than other widely prescribed treatments

A new, once-weekly injection for the treatment of type 2 diabetes controls blood sugar levels better than three other widely prescribed diabetes drugs, late-stage clinical trials show. The drug, dulaglutide, made by Eli Lily and Co., was pitted against the long-used insulin drug metformin, and newer type 2 medications Byetta, made by Bristol-Myers Squibb, and Januvia, made by Merck & Co. Januvia is one of the leaders in diabetes treatment with sales topping $4 billion a year. Dulaglutide performed better at lowering blood sugar levels compared to metformin, Byetta and Januvia. Patients on dulaglutide also lost twice as much weight ... Read More

Medtronic issues urgent medical device safety notice regarding infusion pumps

Medtronic has issued an urgent medical device safety notification to patients and health care providers regarding its Paradigm Infusion Set Connectors, which connect to Medtronic Paradigm infusion sets used to administer insulin to diabetic patients in order to maintain blood glucose levels. Vents can become blocked if insulin or other fluids come in contact with the inside of the connector on the Medtronic Paradigm infusion sets. If the pump’s vents are blocked, this can potentially result in too much or too little insulin being delivered, which may cause hypoglycemia or hyperglycemia. In extreme cases, these conditions may cause loss of consciousness or death. According to the safety notification, ... Read More

Cholesterol-lowering drug Lipitor associated with risk of developing type 2 diabetes

Cholesterol-lowering drugs may increase the chances of developing type 2 diabetes, according to a large Canadian study. The risk is grater for patients taking Lipitor (atorvastatin), Crestor (rosuvastatin), and Zocor (simvastatin). All three drugs are in a class of medications known as statins. They lower cholesterol by inhibiting the enzyme HMG-CoA reductace, which plays a central role in the production of cholesterol in the liver. Elevated cholesterol levels have been associated with cardiovascular diseases, and statins are used to help prevent these diseases. Statins have been effective in lowering cholesterol but they do carry adverse events, specifically muscle damage. The ... Read More

Japan approves new type 2 diabetes treatment still under review in US

Japan’s Ministry of Health, Labour and Welfare has approved Sanofi’s Type 2 diabetes treatment Lyxumia (lixsenatide). The medication is already being sold in Mexico, the European Union, and Australia, and is currently under review in the United States. Lyxumia is the first diabetes treatment in its class in Japan. It is used in combination with basal insulin. The drug is a potent and highly selective GLP-1 peptide agonist. Other GLP-1 drugs that are marketed in the United States include Byetta and Victoza. GLP-1 is a naturally occurring peptide that is released within minutes after one eats a meal. It is ... Read More

GSK’s experimental diabetes drug shows mixed results in clinical trials

Drug maker GlaxoSmithKline (GSK) keeps testing its experimental Type 2 diabetes drug albiglutide against other already approved diabetes drugs, but the results are less than appealing. The latest study, pitting albiglutide against Takeda Pharmaceuticals’ Actos, showed GSK’s drug did not control blood sugar better than Actos. Plus, albiglutide gave patients more gastrointestinal distress than the once-blockbuster medication Actos. It’s a hard pill to swallow for GSK, especially since another of its eight late-stage clinical studies revealed albiglutide did not work as well as Novo Nordisk’s Victoza. The one benefit albiglutide does have is that it is taken once weekly, as ... Read More

High doses of NSAIDs put users at risk of heart attacks, strokes

Millions of people take nonsteroidal anti-inflammatory drugs (NSAIDs) to treat mild to moderate pain, but new research shows the medication may put users at risk for heart attacks and strokes. NSAIDs are in a class of painkillers that includes the medications aspirin, ibuprofen and naproxen. They are sold over-the-counter in both generic version and brand names such as Advil, Motrin and Aleve. Prescription NSAIDs are also available. The most common side effects associated with the drugs includes stomach upset and ulcers. They may also interfere with kidney function. The new study showed that high doses of these drugs taken regularly can increase ... Read More

Will Novo Nordisk be the next company to drop Paula Deen for making racist comments?

Celebrity Chef Paula Deen’s confession that she has used the “N word” and told jokes that could be perceived as racist during a video deposition as part of a $1.2 million lawsuit filed against her by a former employee has landed her in a mess of trouble and it seems she just can’t bail herself out. When trying to rationalize why she told racial jokes she replied, “It’s just what they are – they’re jokes… most jokes are about Jewish people, rednecks, black folks…Gays or straights, black, redneck, you know. I just don’t know – I just don’t know what ... Read More

Byetta may improve Parkinson’s symptoms but side effects are concerning

The type 2 diabetes drug Byetta may help improve Parkinson’s disease symptoms in diabetics, a small study published in the Journal of Clinical Investigation suggests. The study involved 44 people, 20 of whom were regularly given injections of Byetta. The remaining 24 were given a placebo. The patients were followed for 14 months. Patients who were given Byetta injections showed a mean improvement of symptoms of 2.7 points on the MDS-UPDRS scale, a process to measure progression of Parkinson’s disease. The group of patients who were given a placebo declined 2.2 points on the scale. Researchers noted that the findings ... Read More